A detailed history of New Vernon Capital Holdings Ii LLC transactions in Novartis Ag stock. As of the latest transaction made, New Vernon Capital Holdings Ii LLC holds 1,383,244 shares of NVS stock, worth $166 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares
1,383,244
Previous 10,837 12664.09%
Holding current value
$166 Million
Previous $1.05 Million 1077.23%
% of portfolio
0.28%
Previous 0.62%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$97.14 - $115.57 $133 Million - $159 Million
1,372,407 Added 12664.09%
1,383,244 $12.4 Million
Q4 2024

Feb 14, 2025

SELL
$96.78 - $117.18 $244,563 - $296,113
-2,527 Reduced 18.91%
10,837 $1.05 Million
Q3 2024

Nov 14, 2024

BUY
$106.13 - $120.89 $1.42 Million - $1.62 Million
13,364 New
13,364 $1.54 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $259B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track New Vernon Capital Holdings Ii LLC Portfolio

Follow New Vernon Capital Holdings Ii LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Vernon Capital Holdings Ii LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Vernon Capital Holdings Ii LLC with notifications on news.